Welcome to our dedicated page for Marathon Bancorp /MD/ SEC filings (Ticker: MBBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marathon Bancorp /MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marathon Bancorp /MD/'s regulatory disclosures and financial reporting.
Marathon Bancorp, Inc. reported a Schedule 13G/A filing showing the Marathon Bank 401(k) Plan Trust beneficially owns 216,071 shares of Common Stock, representing 7.32% of the class as of 06/30/2026. The trust reports shared voting and dispositive power over those shares. The filing is signed by the trustee's authorized representative on 07/01/2026.
Marathon Bancorp, Inc. reports a Schedule 13G disclosure showing the Marathon Bank 401(k) Plan Trust beneficially owns 193,211 shares of Common Stock, representing 6.57% of the class as of 06/30/2025.
The filing lists shared voting and dispositive power over the 193,211 shares and identifies the trustee as Community Bank of Pleasant Hill, dba First Trust of MidAmerica. The schedule is signed by Gerald Lau as trustee representative.
Marathon Bancorp, Inc. executive Terry Cornish, SVP and Chief Credit Officer, reported updated holdings in company securities. The only actual transaction was a tax-withholding disposition of 247 shares of Common Stock at $15.49 per share, used to cover tax obligations.
After this withholding, Cornish directly holds 6,256 Common shares, plus indirect interests in 2,250 shares through an ESOP and 27,205 shares through a 401(k). Cornish also holds stock options on 7,000 shares at $14.55, 4,804 shares at $6.48, and 4,498 shares at $8.13, with expirations between 2032 and 2036 and vesting at 20% per year as noted in the footnotes.
Marathon Bancorp EVP and COO Michelle Knopf reported routine equity updates. A Form 4 shows a tax-withholding disposition of 225 shares of common stock at $15.49 per share to cover obligations, leaving her with 8,557 directly held shares. She also has indirect holdings of 2,235 shares by ESOP and 19,339 shares by 401(k). Knopf continues to hold stock options for 10,000 shares at $14.55, 4,804 shares at $6.48, and 4,498 shares at $8.13 expiring between 2032 and 2036.
Marathon Bancorp, Inc. President and CEO Nicholas W. Zillges reported updated equity holdings in a Form 4. The only transaction was a Form F tax-withholding disposition of 1,269 shares of Common Stock at $15.49 per share, leaving 55,936 shares of Common Stock held directly.
He also holds Common Stock indirectly through an ESOP (4,429 shares), an IRA (604 shares), and a 401(k) plan (51,160 shares). In addition, he retains stock options over 42,335 shares at $14.55, 3,000 shares at $6.48, and 29,994 shares at $8.13, which vest 20% per year on stated schedules.
Marathon Bancorp, Inc. EVP and CAO Nora Spatz reported a routine tax-related share disposition. On June 28, 2026, 503 shares of common stock were withheld at $15.49 per share to cover tax obligations, leaving 27,096 directly held shares.
Spatz also reports several indirect common stock holdings through a spouse, ESOP, custodial account, trust and 401(k), plus outstanding stock options over 11,000, 2,883 and 2,400 shares at exercise prices of $14.55, $6.48 and $8.13, vesting 20% per year.
Marathon Bancorp, Inc. SVP and CFO Joy Selting-Buchberger reported routine equity activity, mainly a tax-related share disposition. 522 shares of Common Stock were withheld at $15.49 per share as a tax-withholding disposition, leaving 4,760 directly held shares.
She also reports 2,177 shares held through an ESOP and 21,788 shares in a 401(k), both as indirect ownership. In addition, she holds stock options on 4,804 shares at $6.48 expiring on May 16, 2033, and on 5,999 shares at $8.13 expiring on June 28, 2032, which vest over time.
Marathon Bancorp, Inc. President and CEO Nicholas W. Zillges reported an open-market purchase of 970 shares of common stock at $15.00 per share on June 16, 2026, increasing his direct ownership to 57,205 shares.
He also reports indirect holdings of 4,429 shares by an ESOP, 604 shares by an IRA, and 51,160 shares by a 401(k). In addition, he holds stock options on 42,335 shares at $14.55 per share expiring on June 15, 2036, 3,000 shares at $6.48 expiring on May 16, 2033, and 29,994 shares at $8.13 expiring on June 28, 2032, with related vesting schedules described in the filing.
Marathon Bancorp, Inc. director Ann M. Werth reported equity compensation awards rather than market trades. She received a grant of 3,386 shares of common stock at no cost, bringing her directly held common stock to 8,501 shares. She was also granted 8,467 stock options with an exercise price of $14.55 per share, which begin vesting at a rate of 20% per year starting on June 15, 2027.
The filing also lists previously granted stock options covering 900 shares at an exercise price of $6.48 per share and 600 shares at $8.13 per share, expiring in 2033 and 2032, respectively. Footnotes explain that both restricted stock and options vest in 20%-per-year increments from their stated commencement dates, underscoring that these are structured, time-based compensation awards with no reported stock sales.
Marathon Bancorp director Timothy R. Wimmer reported new equity awards in common stock and stock options. He received 3,386 shares of common stock as a grant at no cash cost, bringing his directly held common stock to 6,384 shares, separate from 13,862 shares held indirectly by a trust.
Wimmer was also granted 8,467 stock options on common stock with a $14.55 exercise price, all held directly. The restricted stock and these new options vest 20% per year starting on June 15, 2027, while earlier restricted stock and option awards continue vesting annually from June 28, 2023 and May 16, 2024.